This research was sponsored by the Armed Forces Institute of Regenerative Medicine(AFIRM)award number W81XWH-08-2-0034;The US Army Medical Research Acquisition Activity,820 Chandler Street,Fort Detrick MD 21702-5014 is the awarding and administering acquisition office。
Next-generation synthetic bone graft therapies will most likely be composed of resorbable polymers in combination with bioactive components.In this article,we continue our exploration of E1001(1k),a tyrosine-derived p...